Invasive Carcinoma — Trials

Invasive Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,812 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 603
Recruiting: 301
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 351–354 of 354 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04146077	Active Surveillance for Low Risk Prostate Cancer	recruiting	—	100	I.M. Sechenov First Moscow State Medical UniversityOTHER	1	Jul 22, 2021	clinicaltrials
NCT04900558	Robotic Radical Cystectomy Outcomes	recruiting	—	500	University of FlorenceOTHER	1	May 25, 2021	clinicaltrials